Your email has been successfully added to our mailing list.

×
0 0 0 -0.0357142857142857 0 -0.0428571428571429 -0.05 -0.0714285714285715
Stock impact report

OncoSec's IL-12 construct shows positive effect in preclinical testing; shares ahead 8% premarket [Seeking Alpha]

OncoSec Medical Incorporated (ONCS) 
Last oncosec medical incorporated earnings: 12/13 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: oncosec.com/tag/investor-relations
Company Research Source: Seeking Alpha
Nano cap OncoSec Medical (NASDAQ: ONCS ) perks up   premarket on light volume in response to its announcement of positive preclinical data on its interleukin-12 (IL-12) construct. In a mouse model of melanoma, the company demonstrated that the changes it made to the plasmid design and electroporation parameters significantly increased IL-12 production leading to an anti-tumor effect. It says the new construct will be the backbone of its next-generation combination molecules. The data are being presented today at the American Association of Cancer Research Annual Meeting in Washington, DC. Now read: Oncolytics Biotech's REOLYSIN shows treatment effect in mid-stage breast cancer study » Show less Read more
Impact Snapshot
Event Time:
ONCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ONCS alerts
Opt-in for
ONCS alerts

from News Quantified
Opt-in for
ONCS alerts

from News Quantified